Alnylam announces proposed offering of $500M convertible senior notes

19 hours ago 1

Alnylam Pharmaceuticals (NASDAQ:ALNY) has commenced a private offering of $500 million aggregate principal amount of convertible senior notes due 2028.
The notes will be senior, unsecured obligations of Alnylam, will accrue interest payable semi-annually in arrears and will mature on September 15, 2028, unless